Fluidigm to Present at Leerink Swann 2013 Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Fluidigm Corporation (NAS: FLDM) today announced that President and Chief Executive Officer Gajus Worthington will present at the Leerink Swann 2013 Global Healthcare Conference on Thursday, February 14, 2013, at the Waldorf Astoria Hotel in New York City, beginning at 11:00 a.m. Eastern Time.
Audio and slides of Fluidigm's presentation will be webcast at: http://leerink.metameetings.com/webcasts/healthcare13/directlink?p=61
The webcast will be archived for 90 days following the live presentation.
Fluidigm (NAS: FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigm's proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits (IFCs), assays and other reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets four microfluidic systems, including thirteen different IFCs, to leading academic institutions, diagnostic laboratories, and pharmaceutical, biotechnology and Ag-Bio companies. Fluidigm products are marketed for research purposes only (not for diagnostic use).
For more information, please visit www.fluidigm.com.
Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.
Un Kwon-Casado, 650-266-6035 (office)
KEYWORDS: United States North America California New York
The article Fluidigm to Present at Leerink Swann 2013 Global Healthcare Conference originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.